|
nasdaq:cerc
|
3324084
|
Apr 21st, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 20th, 2024 10:59PM
|
Apr 20th, 2024 11:10PM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|
|
nasdaq:cerc
|
3324084
|
Apr 20th, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 19th, 2024 10:58PM
|
Apr 20th, 2024 04:44PM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|
|
nasdaq:cerc
|
3324084
|
Apr 19th, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 18th, 2024 11:06PM
|
Apr 18th, 2024 11:16PM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|
|
nasdaq:cerc
|
3324084
|
Apr 18th, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 17th, 2024 11:04PM
|
Apr 18th, 2024 06:04PM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|
|
nasdaq:cerc
|
3324084
|
Apr 17th, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 16th, 2024 10:49PM
|
Apr 17th, 2024 02:28PM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|
|
nasdaq:cerc
|
3324084
|
Apr 16th, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 15th, 2024 10:45PM
|
Apr 16th, 2024 10:44AM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|
|
nasdaq:cerc
|
3324084
|
Apr 15th, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 14th, 2024 10:46PM
|
Apr 15th, 2024 04:26PM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|
|
nasdaq:cerc
|
3324084
|
Apr 14th, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 13th, 2024 10:39PM
|
Apr 14th, 2024 10:45AM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|
|
nasdaq:cerc
|
3324084
|
Apr 13th, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 12th, 2024 10:30PM
|
Apr 13th, 2024 11:12AM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|
|
nasdaq:cerc
|
3324084
|
Apr 12th, 2024 12:00AM
|
Avalo Therapeutics
|
2.2K
|
26.00
|
Open
|
|
Apr 11th, 2024 10:33PM
|
Apr 12th, 2024 08:07AM
|
Avalo Therapeutics is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize targeted therapeutics for patients with significant unmet clinical need.
Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success.
We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases.
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
|
Open
|
|
Open
|
540 Gaither Road
|
Rockville
|
Maryland
|
US
|
20850
|
|
Cerecor
|
|
|